Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 20/20 | 0.85 |
| ▸ | MLNR | O43193 | 1/20 | 0.85 |
| ▸ | KDM1A | O60341 | 1/20 | 0.85 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.85 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.85 |
| ▸ | INSR | P06213 | 1/20 | 0.85 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.85 |
| ▸ | HTR1A | P08908 | 1/20 | 0.85 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.85 |
| ▸ | DRD2 | P14416 | 1/20 | 0.85 |
| ▸ | NQO2 | P16083 | 1/20 | 0.85 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.85 |
| ▸ | DRD1 | P21728 | 1/20 | 0.85 |
| ▸ | ERBB3 | P21860 | 1/20 | 0.85 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.85 |
| ▸ | HTR2A | P28223 | 1/20 | 0.85 |
| ▸ | HTR2C | P28335 | 1/20 | 0.85 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.85 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.85 |
| ▸ | CCKAR | P32238 | 1/20 | 0.85 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17683216 | 0.94 | EGFR (0.86) | EGFRMLNRKDM1AABCB11ERBB2 | |
| Osimertinib SCHEMBL29350904 | 0.92 | EGFR (1.00) | EGFRMLNRKDM1AABCB11ERBB2 | |
| Osimertinib SCHEMBL14660911 | 0.92 | EGFR (1.00) | EGFRMLNRKDM1AABCB11ERBB2 | |
| Osimertinib SCHEMBL29378405 | 0.92 | EGFR (1.00) | EGFRMLNRKDM1AABCB11ERBB2 | |
| SCHEMBL22509190 | 0.91 | EGFR (0.88) | EGFRMLNRKDM1AABCB11ERBB2 | |
| SCHEMBL19780930 | 0.89 | EGFR (0.87) | EGFRMLNRKDM1AABCB11ERBB2 | |
| Osimertinib SCHEMBL29375936 | 0.89 | EGFR (0.95) | EGFRMLNRKDM1AABCB11ERBB2 | |
| SCHEMBL17553467 | 0.89 | EGFR (0.85) | EGFRMLNRKDM1AABCB11ERBB2 | |
| Osimertinib SCHEMBL29353024 | 0.89 | EGFR (0.95) | EGFRMLNRKDM1AABCB11ERBB2 | |
| Osimertinib SCHEMBL14661152 | 0.89 | EGFR (0.95) | EGFRMLNRKDM1AABCB11ERBB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10414756-B2 | 2-(2,4,5-substituted aniline) pyrimidine derivative, pharmaceutical composition and use thereof | NANJING DIANSU BIOLOGICAL TECHNOLOGY CO. LTD (CN) | 2019-09-17 | — | — | US | disclosed |
| US-20180016258-A1 | 2-(2,4,5-SUBSTITUTED ANILINE) PYRIMIDINE DERIVATIVE, PHARMACEUTICAL COMPOSITION AND USE THEREOF | NANJING DIANSU BIOLOGICAL TECHNOLOGY CO., LTD (CN) | 2018-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180016258-A1 | 2-(2,4,5-SUBSTITUTED ANILINE) PYRIMIDINE DERIVATIVE, PHARMACEUTICAL COMPOSITION AND USE THEREOF | ABCG2, SLC29A2, TP53 | EGFR 1100/4885MLNR 2200/4885KDM1A 4784/4885 |
| US-10414756-B2 | 2-(2,4,5-substituted aniline) pyrimidine derivative, pharmaceutical composition and use thereof | ABCG2, SLC29A2, TP53 | EGFR 1100/4885MLNR 2200/4885KDM1A 4784/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.